Table 12.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Lung Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		535	674	738	893	836	947	893	919	976	1,073
Tx With Follow-up Immunosuppression Info		405	530	526	637	573	681	661	666	729	781
Corticosteroids	Category Usage	97.8%	98.9%	98.1%	99.1%	99.3%	98.4%	99.5%	99.7%	98.9%	99.5%
	Steroids	97.8%	98.9%	98.1%	99.1%	99.3%	98.4%	99.5%	99.7%	98.9%	99.5%
Cyclosporine	Category Usage	92.6%	91.1%	81.2%	70.5%	70.0%	62.1%	64.4%	64.1%	54.9%	46.4%
	Cyclosporin	91.9%	90.6%	71.7%	1.1%	0.0%	0.0%	0.0%	0.0%	0.3%	0.0%
	Sandimmmune	0.7%	3.4%	8.0%	35.5%	14.5%	8.4%	6.7%	4.5%	4.3%	5.1%
	Neoral	0.2%	0.2%	2.7%	37.4%	56.4%	54.9%	58.7%	59.3%	49.2%	35.5%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.5%	2.9%	7.2%
	Eon	0.0%	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%	0.3%	0.1%	0.1%
Tacrolimus	Category Usage	6.9%	9.6%	12.0%	23.4%	33.9%	37.9%	41.8%	47.0%	55.8%	68.5%
	FK506	6.9%	9.6%	12.0%	23.4%	33.9%	37.9%	41.8%	47.0%	55.8%	68.5%
Antimetabolites	Category Usage	96.8%	97.4%	95.8%	89.8%	88.3%	88.0%	92.1%	92.0%	94.2%	90.9%
	Azathioprine	96.8%	97.4%	94.5%	79.3%	68.4%	57.7%	62.3%	58.3%	53.8%	49.3%
	Mycophenolate mofetil	0.0%	0.2%	1.5%	12.7%	23.9%	32.9%	37.4%	41.1%	48.7%	51.9%
Other	Category Usage	0.2%	0.6%	0.8%	0.6%	0.3%	0.6%	0.3%	6.3%	6.7%	11.3%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	6.0%	6.2%	11.0%
	Cytoxan	0.2%	0.6%	0.8%	0.6%	0.3%	0.6%	0.2%	0.3%	0.7%	0.3%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.